Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0849-2013Class II

NEUROPATH 6Fx100 GUIDING CATH ST

Cerenovus, Inc. / initiated 2013-01-11 / Terminated / root cause: design

Codman & Shurtleff, Inc. began a recall of NEUROPATH 6Fx100 GUIDING CATH ST Product Code: GST61000000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of... on . FDA classified it as Class II and gives the reason as "Sterility of device may be compromised due to lack of package integrity". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-0849-2013
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Cerenovus, Inc.
Product
NEUROPATH 6Fx100 GUIDING CATH ST Product Code: GST61000000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices
Product code
DQY Catheter, Percutaneous
Reason for recall
Sterility of device may be compromised due to lack of package integrity
Root cause tag
design
FDA root cause
Component design/selection
Action
Codman sent an Urgent Voluntary Product Recall Notification letter dated January 11, 2013, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were advised to check all inventory to determine if they have any affected product, use the included instructions to report inventory status, return and obtain replacement product. Customers were instructed to contact your local Codman Representative or Stericycle at 1-866-201-9077. For questions regarding this recall call 508-880-8100.
Quantity in commerce
266 units
Distribution
Worldwide Distribution - USA (nationwide) and Internationally to Austria, Belgium, Canada, Chile, Costa, Rica, Czech Republic, Denmark, France, Germany, Great Britian/UK, Ireland, Italy, Lithuania, Malaysia, Netherlands, New Zealand, Norway, Poland, Portugal, Singapore, Slovakia, Spain, and Switzerland.
Product codes and lots
All unexpired lots

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0849-2013
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0842-2013Class IITerminatedVoluntary: Firm initiated
Z-0843-2013Class IITerminatedVoluntary: Firm initiated
Z-0844-2013Class IITerminatedVoluntary: Firm initiated
Z-0845-2013Class IITerminatedVoluntary: Firm initiated
Z-0846-2013Class IITerminatedVoluntary: Firm initiated
Z-0847-2013Class IITerminatedVoluntary: Firm initiated
Z-0848-2013Class IITerminatedVoluntary: Firm initiated
Z-0849-2013Class IITerminatedVoluntary: Firm initiated
Z-0850-2013Class IITerminatedVoluntary: Firm initiated
Z-0851-2013Class IITerminatedVoluntary: Firm initiated
Z-0852-2013Class IITerminatedVoluntary: Firm initiated
Z-0853-2013Class IITerminatedVoluntary: Firm initiated
Z-0854-2013Class IITerminatedVoluntary: Firm initiated
Z-0855-2013Class IITerminatedVoluntary: Firm initiated
Z-0856-2013Class IITerminatedVoluntary: Firm initiated
Z-0857-2013Class IITerminatedVoluntary: Firm initiated
Z-0858-2013Class IITerminatedVoluntary: Firm initiated
Z-0859-2013Class IITerminatedVoluntary: Firm initiated
Z-0860-2013Class IITerminatedVoluntary: Firm initiated
Z-0861-2013Class IITerminatedVoluntary: Firm initiated
Z-0862-2013Class IITerminatedVoluntary: Firm initiated
Z-0863-2013Class IITerminatedVoluntary: Firm initiated
Z-0864-2013Class IITerminatedVoluntary: Firm initiated
Z-0865-2013Class IITerminatedVoluntary: Firm initiated